Júlia Perera‐Bel

806 total citations
17 papers, 340 citations indexed

About

Júlia Perera‐Bel is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Júlia Perera‐Bel has authored 17 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Júlia Perera‐Bel's work include Cancer Genomics and Diagnostics (4 papers), Genomics and Rare Diseases (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Júlia Perera‐Bel is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Genomics and Rare Diseases (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Júlia Perera‐Bel collaborates with scholars based in Spain, Germany and United States. Júlia Perera‐Bel's co-authors include Caterina R. Giner, Silvia G. Acinas, Massimo C. Pernice, Ramón Massana, Ramiro Logares, Carlos M. Duarte, Josep M. Gasol, Tim Beißbarth, Annalen Bleckmann and Florian Auer and has published in prestigious journals such as Nature Communications, Scientific Reports and Science Advances.

In The Last Decade

Júlia Perera‐Bel

14 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Júlia Perera‐Bel Spain 8 240 138 74 41 34 17 340
Qinghua Qi China 10 103 0.4× 20 0.1× 77 1.0× 44 1.1× 12 0.4× 32 334
Wanxue Xu China 8 107 0.4× 60 0.4× 38 0.5× 37 0.9× 6 0.2× 13 258
Xia Lin China 10 110 0.5× 64 0.5× 81 1.1× 5 0.1× 9 0.3× 35 307
Mattia D’Antonio Italy 12 397 1.7× 48 0.3× 94 1.3× 9 0.2× 5 0.1× 25 497
Congting Ye China 19 530 2.2× 61 0.4× 79 1.1× 11 0.3× 7 0.2× 43 768
Thomas Wolfgruber United States 13 303 1.3× 22 0.2× 65 0.9× 4 0.1× 26 0.8× 24 599
Xuetong Zhao China 8 306 1.3× 25 0.2× 61 0.8× 3 0.1× 10 0.3× 23 388
Danila Bredikhin Germany 5 546 2.3× 11 0.1× 96 1.3× 7 0.2× 20 0.6× 7 645
Shaoping Ling China 5 80 0.3× 15 0.1× 64 0.9× 6 0.1× 27 0.8× 8 182
Jeffery B. Leirness United States 4 268 1.1× 56 0.4× 90 1.2× 8 0.2× 7 0.2× 4 493

Countries citing papers authored by Júlia Perera‐Bel

Since Specialization
Citations

This map shows the geographic impact of Júlia Perera‐Bel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Júlia Perera‐Bel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Júlia Perera‐Bel more than expected).

Fields of papers citing papers by Júlia Perera‐Bel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Júlia Perera‐Bel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Júlia Perera‐Bel. The network helps show where Júlia Perera‐Bel may publish in the future.

Co-authorship network of co-authors of Júlia Perera‐Bel

This figure shows the co-authorship network connecting the top 25 collaborators of Júlia Perera‐Bel. A scholar is included among the top collaborators of Júlia Perera‐Bel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Júlia Perera‐Bel. Júlia Perera‐Bel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bellmunt, Joaquim, Júlia Perera‐Bel, Gardenia Vargas‐Parra, et al.. (2025). Prognostic Value of PARP1 and PARP2 Copy Number Alterations in Prostate Cancer. Laboratory Investigation. 105(6). 104171–104171.
2.
3.
González, Núria, Francesca Guijarro, Marta Pratcorona, et al.. (2025). CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases. Diagnostic Pathology. 20(1). 56–56.
4.
Castelo, Robert, et al.. (2025). Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts. Nature Communications. 16(1). 1213–1213. 4 indexed citations
5.
Ruiz, Marta, Jorge Ruiz‐Orera, Robert Castelo, et al.. (2024). Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort. Science Advances. 10(28). eadn3628–eadn3628. 17 indexed citations
6.
Juanpere, Núria, Marta Lorenzo, David López, et al.. (2023). Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(2). 281–290. 2 indexed citations
7.
Rombauts, Alexander, Gabriela Abelenda-Alonso, Júlia Perera‐Bel, et al.. (2023). Dynamics of Gene Expression Profiling and Identification of High-Risk Patients for Severe COVID-19. Biomedicines. 11(5). 1348–1348. 8 indexed citations
8.
Perera‐Bel, Júlia, Alejo Rodríguez‐Vida, Oriol Arpí, et al.. (2023). The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer. Scientific Reports. 13(1). 15287–15287. 6 indexed citations
9.
Jong, Joep J. de, Begoña P. Valderrama, Júlia Perera‐Bel, et al.. (2022). Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis. British Journal of Cancer. 127(2). 313–320. 13 indexed citations
10.
García‐Giralt, Natalia, Juan Du, Judith Marín‐Corral, et al.. (2022). Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection. Scientific Reports. 12(1). 6929–6929. 25 indexed citations
11.
Perera‐Bel, Júlia, et al.. (2022). Identifying Actionable Variants in Cancer – The Dual Web and Batch Processing Tool MTB-Report. Studies in health technology and informatics. 296. 73–80. 8 indexed citations
12.
Bleckmann, Annalen, Kerstin Menck, Júlia Perera‐Bel, et al.. (2021). Explaining decisions of graph convolutional neural networks: patient-specific molecular subnetworks responsible for metastasis prediction in breast cancer. Genome Medicine. 13(1). 42–42. 70 indexed citations
13.
Rocha, Pedro, Mayra Orrillo, Álvaro Taus, et al.. (2020). Comparison of Different Methods for Defining Hyperprogressive Disease in NSCLC. JTO Clinical and Research Reports. 2(1). 100115–100115. 3 indexed citations
14.
Beißbarth, Tim, Annalen Bleckmann, Gunnar Duttge, et al.. (2019). Clinical application of genomic high-throughput data: Infrastructural, ethical, legal and psychosocial aspects. European Neuropsychopharmacology. 31. 1–15. 5 indexed citations
15.
Perera‐Bel, Júlia, Barbara Hutter, Christoph Heining, et al.. (2018). From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards. Genome Medicine. 10(1). 18–18. 27 indexed citations
16.
Perera‐Bel, Júlia, et al.. (2018). Using RNA-Seq Data for the Detection of a Panel of Clinically Relevant Mutations. Studies in health technology and informatics. 253. 217–221. 5 indexed citations
17.
Pernice, Massimo C., Caterina R. Giner, Ramiro Logares, et al.. (2015). Large variability of bathypelagic microbial eukaryotic communities across the world’s oceans. The ISME Journal. 10(4). 945–958. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qinghua Qi Breakdown of academic impact, for papers by Wanxue Xu Breakdown of academic impact, for papers by Xia Lin Breakdown of academic impact, for papers by Mattia D’Antonio Breakdown of academic impact, for papers by Congting Ye Breakdown of academic impact, for papers by Thomas Wolfgruber Breakdown of academic impact, for papers by Xuetong Zhao Breakdown of academic impact, for papers by Danila Bredikhin Breakdown of academic impact, for papers by Shaoping Ling Breakdown of academic impact, for papers by Jeffery B. Leirness
Rankless by CCL
2026